Evidence map›Paper›PMID 35264978›Full record

ArticleFrontiers in physiology2022

Cell-to-Cell Communications in Alcohol-Associated Liver Disease.

Natalia A Osna, Akiko Eguchi, Ariel E Feldstein, Hidekazu Tsukamoto, Raghubendra S Dagur, Murali Ganesan, Moses New-Aaron, Madan Kumar Arumugam, Srinivas Chava, Marcelle Ribeiro and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Natalia A OsnaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Akiko EguchiDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.
Ariel E FeldsteinDepartment of Pediatrics, University of California, San Diego, San Diego, CA, United States.
Hidekazu TsukamotoSouthern California Research Center for ALPD and Cirrhosis and Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Raghubendra S DagurResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Murali GanesanResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Moses New-AaronResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Madan Kumar ArumugamResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Srinivas ChavaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
Marcelle RibeiroHarvard Medical School and Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Gyongyi SzaboHarvard Medical School and Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Sebastian MuellerSalem Medical Center and Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.
Shijin WangSalem Medical Center and Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.
Cheng ChenSalem Medical Center and Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.
Steven A WeinmanDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
Kusum K KharbandaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE, United States.
VA Nebraska Western Iowa Health Care System · USHeidelberg University · DEUniversity of Nebraska Medical Center · USBeth Israel Deaconess Medical Center · USHarvard University · USMie University · JPUniversity of California, San Diego · USUniversity of Kansas Medical Center · USVA Greater Los Angeles Healthcare System · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HIDEKAZU TSUKAMOTO · 1999 to 2026
$45.8M
longitudinal assessment of stress and stress-related concepts across a behavioral weight loss interventionP20GM144269 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, STEVEN A WEINMAN · 2022 to 2026
$14.9M
Role of alcohol adapted Kupffer cells in the progression and resolution of ALDR01AA012863 · NIAAA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI STEVEN A WEINMAN · 2000 to 2026
$10.2M
NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
MicroRNAs in Alcoholic Liver Disease Administrative SupplementR01AA020744 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2011 to 2023
$5.3M
TLR4 Signaling in alcoholic liver diseaseR01AA017729 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2009 to 2021
$4.3M
Hepatocyte-derived extracellular vesicles in alcoholic liver diseaseR01AA028134 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDSTEIN, ARIEL, TSUKAMOTO, HIDEKAZU · 2020 to 2024
$2.9M
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosisR01AA026723 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KHARBANDA, KUSUM K. · 2018 to 2022
$1.6M
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical DiscoveryUH3AA026970 · NIAAA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SZABO, GYONGYI · 2020 to 2022
$1.3M
Ethanol suppresses HBV peptide-MHC Class I presentation on hepatocytesK01AA026864 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GANESAN, MURALI · 2018 to 2022
$684k
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical DiscoveryUH2AA026970 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2018 to 2019
$461k
Hepatocyte-hepatic stellate cell axis in potentiation of alcohol and HIV-induced liver injuryF31AA028743 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI NEW-AARON, MOSES O · 2021 to 2022
$86k
BLRD VA I01 BX004053BLRD VA I01 BX004694NIAAA NIH HHS F31 AA028743NIAAA NIH HHS K01 AA026864NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA012863NIAAA NIH HHS R01 AA017729NIAAA NIH HHS R01 AA020744NIAAA NIH HHS R01 AA026723NIAAA NIH HHS R01 AA028134NIAAA NIH HHS R24 AA012885NIAAA NIH HHS UH2 AA026970NIAAA NIH HHS UH3 AA026970NIGMS NIH HHS P20 GM144269
6 · The paper itself

Abstract

This review covers some important new aspects of the alcohol-induced communications between liver parenchymal and non-parenchymal cells leading to liver injury development. The information exchange between various cell types may promote end-stage liver disease progression and involves multiple mechanisms, such as direct cell-to-cell interactions, extracellular vesicles (EVs) or chemokines, cytokines, and growth factors contained in extracellular fluids/cell culture supernatants. Here, we highlighted the role of EVs derived from alcohol-exposed hepatocytes (HCs) in activation of non-parenchymal cells, liver macrophages (LM), and hepatic stellate cells (HSC). The review also concentrates on EV-mediated crosstalk between liver parenchymal and non-parenchymal cells in the settings of HIV- and alcohol co-exposure. In addition, we overviewed the literature on the crosstalk between cell death pathways and inflammasome activation in alcohol-activated HCs and macrophages. Furthermore, we covered highly clinically relevant studies on the role of non-inflammatory factors, sinusoidal pressure (SP), and hepatic arterialization in alcohol-induced hepatic fibrogenesis. We strongly believe that the review will disclose major mechanisms of cell-to-cell communications pertained to alcohol-induced liver injury progression and will identify therapeutically important targets, which can be used for alcohol-associated liver disease (ALD) prevention.

Indexed as

alcohol hepatitisextracellular vesiclesfibrosisHIVliver stiffnesspyroptosis

Identifiers

PMID35264978
PMCPMC8899290
OpenAlexW4212995396

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.